Main

Fields of interest:

• General and regional anesthesia
• Ssepsis
• Pulmonary hypertension
• Pain therapy

Recent publications:

V. Winter, E. Czeslick, A. Sablotzki:
Sepsis and multiple organ dysfunctions � pathophysiology and the topical concepts of treatment,
Anesteziol. Reanimatol., Vol. 5, (2007), pp. 66.

D. Payen, P. S. Barie, A. Sablotzki, et al.:
International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: analysis of efficacy and safety data in a large surgical cohort,
Surgery, Vol. 141, (2007), pp. 548.

E. Czeslick, A. Struppert, A. Simm, A. Sablotzki:
E5564 (Eritoran) inhibits lipopolysaccharide-induced cytokine production in human blood monocytes,
Inflamm. Res., Vol. 55, (2006), pp. 511.

A. Sablotzki, T. Hentschel, S. Hofmann, A. Simm. J. Mühling, E. Czeslick:
Inhaled aerosolized iloprost in the evaluation of heart transplant candidates--experiences with 45 cases,
J. Clin. Anesth., Vol. 18, (2006), pp. 108.

A. Sablotzki, M. G. Dehne, E. Czeslick:
Supportive treatment measures in severe sepsis,
Anaesthesiol. Intensivmed. Notfallmed. Schmerzther., Vol. 41, (2006), pp. 37.

A. Sablotzki, W. Starzmann, R. Scheubel, S. Grond, E. Czeslick:
Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates,
Can. J. Anaesth., Vol. 52, (2005), pp. 1076.